ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

A Texas Radiation Center’s Survival Move Draws M.D. Anderson Into PPM Competition

February 27, 1998

In Brief: Senate committee Oks Another Cigarette Tax Hike; NCI Seeking Cancer Control Science Head

August 1, 1986

Bill Requires NIH-Funded Researchers To Send Manuscripts To PubMed Central.

November 2, 2007

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006

Edward Harlow Returns to NCI As Special Assistant to Varmus

January 14, 2011

Clearinghouse Agrees On Three Big New Carcinogens

May 4, 1979